SCHEMBL4229796

SCHEMBL4229796

Nc1ccccc1NC(=O)c1ccc(C(CCC(=O)O)NC(=O)Nc2ccc3c(c2)OCCO3)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 8/20 0.53
RAB9A P51151 8/20 0.44
NPC1 O15118 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
PKM P14618 1/20 0.44
HDAC3 O15379 7/20 0.44
HDAC8 Q9BY41 3/20 0.44
MAPT P10636 4/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 1/20 0.43
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4225149 0.88 HDAC1 (0.50) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL4368308 0.86 HDAC1 (0.47) HDAC1SMN1; SMN2HDAC3HDAC8MAPT
SCHEMBL4365544 0.85 HDAC1 (0.47) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL2473990 0.79 HDAC1 (0.67) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL3218525 0.79 SMN1; SMN2 (0.41) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL2474374 0.78 HDAC1 (0.65) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL2477893 0.77 HDAC1 (0.64) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL4219712 0.77 UTS2R (0.39) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL4229101 0.77 ALDH1A1 (0.39) HDAC1RAB9ANPC1SMN1; SMN2PKM
SCHEMBL4229785 0.76 HDAC1 (0.47) HDAC1RAB9ANPC1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2135620-A1 OCULAR HYPOTENSIVE AGENT COMPRISING COMPOUND CAPABLE OF INHIBITING HISTONE DEACETYLASE AS ACTIVE INGREDIENT Santen Pharmaceutical Co., Ltd (JP) 2009-12-23 EP disclosed
EP-2133339-A1 NOVEL (2-AMINOPHENYL)PYRIDINECARBOXAMIDE DERIVATIVE HAVING UREA STRUCTURE Santen Pharmaceutical Co., Ltd (JP) 2009-12-16 EP disclosed